Unknown

Dataset Information

0

Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities.


ABSTRACT:

Objective

To analyse differences in clinical presentation and outcome between bacteraemic pneumococcal community-acquired pneumonia (B-PCAP) and sSvere Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) pneumonia.

Methods

This observational multi-centre study was conducted on patients hospitalized with B-PCAP between 2000 and 2020 and SARS-CoV-2 pneumonia in 2020. Thirty-day survival, predictors of mortality, and intensive care unit (ICU) admission were compared.

Results

In total, 663 patients with B-PCAP and 1561 patients with SARS-CoV-2 pneumonia were included in this study. Patients with B-PCAP had more severe disease, a higher ICU admission rate and more complications. Patients with SARS-CoV-2 pneumonia had higher in-hospital mortality (10.8% vs 6.8%; P=0.004). Among patients admitted to the ICU, the need for invasive mechanical ventilation (69.7% vs 36.2%; P<0.001) and mortality were higher in patients with SARS-CoV-2 pneumonia. In patients with B-PCAP, the predictive model found associations between mortality and systemic complications (hyponatraemia, septic shock and neurological complications), lower respiratory reserve and tachypnoea; chest pain and purulent sputum were protective factors in these patients. In patients with SARS-CoV-2 pneumonia, mortality was associated with previous liver and cardiac disease, advanced age, altered mental status, tachypnoea, hypoxaemia, bilateral involvement, pleural effusion, septic shock, neutrophilia and high blood urea nitrogen; in contrast, ≥7 days of symptoms was a protective factor in these patients. In-hospital mortality occurred earlier in patients with B-PCAP.

Conclusions

Although B-PCAP was associated with more severe disease and a higher ICU admission rate, the mortality rate was higher for SARS-CoV-2 pneumonia and deaths occurred later. New prognostic scales and more effective treatments are needed for patients with SARS-CoV-2 pneumonia.

SUBMITTER: Serrano Fernandez L 

PROVIDER: S-EPMC8598257 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8542522 | biostudies-literature
2020-12-10 | GSE152641 | GEO
| S-EPMC9251468 | biostudies-literature
| S-EPMC7786129 | biostudies-literature
| S-EPMC9251468 | biostudies-literature
| S-EPMC7911974 | biostudies-literature
| S-BSST379 | biostudies-other
| S-EPMC4577046 | biostudies-literature
2021-09-30 | GSE184949 | GEO
| S-EPMC7586649 | biostudies-literature